Every podcast, panel, conference, and feature, in one place.
Lauren Alani is Director of Digital Innovation at Seuss+ and chaired the ACDM eDigital Data Management Expert Group from 2019 to 2024. This page lists the full archive of her media appearances: podcast guest spots, conference keynotes, regulatory roundtables, panel discussions, and press features. Topics span sponsor accountability for clinical data integrity, the regulator-vendor gap, requirements-led clinical technology selection, and data integrity as commercial risk for clinical-stage biotech assets. To book Lauren for a podcast, panel, conference, or press feature, contact Gina Dunn, Director of Marketing at Seuss+, at g.dunn@consultseuss.com.
All appearances, most recent first.
Filter by format above the grid. Each card links to the source recording, transcript, or article where available.

ArkFest 2025 — Lauren Alani (Seuss+) named speaker
ArkFest 2025 is Arkivum's free, online digital-archiving-and-preservation conference (15–17 July 2025) for professionals in pharma, higher education, and cultural heritage. Lauren appears on the speakers…


Lauren Alani on Revolutionising Clinical Trials Through AI, Diversity, and Innovation
Welcome to Trail Blazers latest episode, where we delve into the fascinating and complex world of clinical research, exploring how innovative technologies are revolutionising the…

ArkFest 2025 (Arkivum, virtual)
Compliance, data integrity and operational efficiency in pharma

Showcasing Biotech Success Stories: Digital Endpoints in Clinical Trials
DiMe's official webinar landing page for the 28 January 2025 panel on biotech adoption of digital endpoints. The page hosts the recording, slides, and panellist/moderator…

Showcasing biotech success stories: Digital endpoints in clinical trials
YouTube replay of the DiMe webinar where Lauren served as a biotech digital-innovation panellist. The video is publicly hosted and linked from the DiMe webinar…

Lauren Alani to Share Insights at DiMe Webinar on Digital Endpoints in Biotech
Seuss+ blog announcement that Lauren Alani, Director of Digital Innovation, would speak on the DiMe webinar 'Showcasing Biotech Success Stories: Digital Endpoints in Clinical Trials'…

What do we need to do to safeguard clinical data integrity? Crosschecking current guidance.
Long-form authored thought-leadership article by Lauren comparing data-integrity expectations across the ICH E6(R3) draft, EMA's 2023 guideline on computerised systems, and FDA guidance (DHTs 2023,…

Cut the Chat hub — featured episode card naming Lauren Alani
Seuss+ podcast hub page listing all Cut the Chat episodes. The S2 E3 card explicitly names Lauren as a featured guest and links to her…

Episode: S2 E3 — Transforming Clinical Trials: How Digital Endpoints Are Leading the Way
Season 2, Episode 3 of Seuss+'s Cut the Chat podcast. Lauren joined Victoria Bangieva of DiMe to discuss DiMe's 'Building the Business Case for Digital…

Life Science Insider Podcast (Seuss+) — S2 E3
In the third episode of season 2, host Sabine Hutchison, Seuss+ CEO and Co-Founder, is joined by Victoria Bangieva from the Digital Medicine Society (DiMe)…

Gender Pay Gap Snapshot 2024
HBA Europe / Aon 2024 gender pay gap report co-authored by Lauren Alani and four other HBA volunteer authors. Reports a current 12.3% median pay…
Inviting Lauren for a stage, podcast, panel, or feature.
All booking enquiries route to Gina Dunn, Director of Marketing at Seuss+. Please include the format, audience, date window, and the angle you are exploring. Lauren personally reviews each invitation; Gina handles scheduling, briefing, and any pre-record logistics.
Format, scope, and editorial.
What topics will Lauren take on?
Sponsor accountability for clinical trial data integrity; the structural gap between regulator expectations and vendor accountability; trial-level requirements as the discipline that should precede clinical technology selection; and data integrity as enterprise and commercial risk for clinical-stage biotech assets. Lauren also speaks to ICH GCP E6(R3) implementation, ALCOA+ in practice, ACDM whitepaper findings, and the operational realities of decentralised and hybrid trials.
What topics will Lauren decline?
Named client case studies, vendor comparisons by product name, regulatory advice for a specific trial or asset, and topics outside the four core lanes covered on this site. Lauren does not provide on-air advisory recommendations; her role on a programme is to surface structural patterns and questions sponsors should be asking, not to substitute for qualified regulatory or legal counsel.
How far in advance should we book?
For podcasts and remote panels, two to four weeks is typical. For conference keynotes and in-person panels, eight to twelve weeks gives time for proper preparation, alignment on the angle, and any pre-event collateral. Tight-turnaround press features and reactive commentary on regulatory developments are considered case by case.
Does Lauren accept paid speaking engagements?
Speaking fees and honoraria are considered for industry conferences, sponsor-organised events, and commercial programmes. Editorial podcasts, peer-reviewed academic events, and not-for-profit programmes are typically accepted on an unpaid basis. Travel and accommodation arrangements for in-person events are agreed in advance through Gina Dunn.
Can we license a clip, quote, or excerpt?
Brief quotations with attribution and a link to the source are welcomed. For longer-form licensing, syndication, or republication of an interview, contact Gina Dunn, Director of Marketing at Seuss+, at g.dunn@consultseuss.com. Clip use in vendor marketing materials requires written approval.
Is there a pressroom or media kit?
A short bio, headshot, and topic one-pager are available on request. The media page carries the standard one-line bio, the questioning method, and the four core topics. For high-resolution assets or a tailored brief, email Gina Dunn.